These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25856998)

  • 1. [Differential diagnosis].
    Koshita S; Kobayashi G; Noda Y; Ito K; Kanno Y
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():119-24. PubMed ID: 25856998
    [No Abstract]   [Full Text] [Related]  

  • 2. [X-ray and radioisotopic investigational methods in tumors of the duodenopancreaticobiliary area].
    Gabuniia RI; Petsko AR; Vinogradov VA; Kuvshinov IuP
    Med Radiol (Mosk); 1980 Sep; 25(9):48-53. PubMed ID: 7421440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytological diagnosis of neoplasms of the duodenal, hepatic, pancreatic and biliary system].
    Shida S; Matsuzawa Y; Muto K; Takada E
    Rinsho Byori; 1980; Suppl():165-76. PubMed ID: 7411956
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pancreatic and biliary tract cancers].
    Sawada T; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):865-71. PubMed ID: 11432359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of cancer of the bilio-pancreatoduodenal region].
    Lebedev NV; Merzhanov PA
    Sov Med; 1990; (11):33-8. PubMed ID: 2075520
    [No Abstract]   [Full Text] [Related]  

  • 6. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nuclear spin resonance in the diagnosis of the upper abdomen].
    Hamm B; Wolf KJ; Felix R
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1630-6. PubMed ID: 3311691
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 levels in the evaluation of malignant/benign pancreaticobiliary disease: hope or hype?
    Gessner CE; Baillie J
    Am J Gastroenterol; 1996 Feb; 91(2):401-2. PubMed ID: 8607524
    [No Abstract]   [Full Text] [Related]  

  • 10. Duodenal endoscopic approach: ERCP.
    Vecchioli A; Belli P; Ortenzi M; Marano P
    Rays; 1989; 14(1):27-35. PubMed ID: 2520854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Computerized methods in the diagnosis and prognosis of surgically treated bilio-pancreatic diseases].
    Festa T; Foco A; Serenthà U; Enrichens F; Sciascia C; Caponi R; Manconi P; Grande L; Vogliolo B; Cardone M; Fornero G; Barberio V; Giordano A; Curti B; Pasquino M
    Minerva Med; 1983 Feb; 74(7):289-300. PubMed ID: 6338420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic detection of small pancreaticoduodenal and biliary cancers in the early developmental stage.
    Yamada T; Murohisa B; Muto Y; Okamoto K; Doi K; Tsuchiya R
    Acta Cytol; 1984; 28(4):435-42. PubMed ID: 6589923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of peripapillary carcinoma: endoscopic findings.
    Takeda Y; Eriguchi M; Yanagie H; Akiyama N; Shimizu H; Yoshizaki I; Takahashi T; Fujii Y; Mikamo Y; Samaru Y
    Biomed Pharmacother; 1989; 43(6):439-46. PubMed ID: 2686772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic endoscopic retrograde cholangiopancreatography.
    Shimizu S; Kutsumi H; Fujimoto S; Kawai K
    Endoscopy; 1998 Feb; 30(2):158-62. PubMed ID: 9592657
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases.
    Ozkan H; Akar T; Köklü S; Coban S
    Pancreatology; 2006; 6(4):268-72. PubMed ID: 16636598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum testosterone:dihydrotestosterone ratio and CA 19-9 in the diagnosis of pancreatic cancer.
    Robles-Díaz G; Díaz-Sánchez V; Fernández-del Castillo C; Morales M; Aceves G; Galván E; Altamirano A
    Am J Gastroenterol; 1991 May; 86(5):591-4. PubMed ID: 2028950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic biopsy.
    Forsgren L; Hansson K; Lundh G; Nordenstam H
    Acta Chir Scand; 1968; 134(6):457-60. PubMed ID: 5731287
    [No Abstract]   [Full Text] [Related]  

  • 18. Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma.
    Brockmann JG; Hernandez CA; Emparan C; Wolters H; Haier J; Dietl KH; Senninger NJ
    Anticancer Res; 2003; 23(2A):819-25. PubMed ID: 12820306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice].
    Skvortsov SV; Lytsar' BN; Kalinin AV; Dolinskiĭ AG
    Klin Med (Mosk); 1992; 70(5-6):21-3. PubMed ID: 1279265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.